BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 12561120)

  • 1. Stable oligonucleotide-directed triplex formation at target sites with CG interruptions: strong sequence-specific recognition by 2',4'-bridged nucleic-acid-containing 2-pyridones under physiological conditions.
    Obika S; Hari Y; Sekiguchi M; Imanishi T
    Chemistry; 2002 Oct; 8(20):4796-802. PubMed ID: 12561120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2',4'-BNA derivatives bearing an unnatural nucleobase: synthesis and application to triplex-forming oligonucleotides.
    Inohara H; Obika S; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2004; (48):63-4. PubMed ID: 17150479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2',4'-BNA bearing unnatural nucleobases: toward the expansion of the target sequence of double-stranded DNA in triplex formation.
    Obika S; Hari Y; Inohara H; Imanishi T
    Nucleic Acids Res Suppl; 2001; (1):171-2. PubMed ID: 12836319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2',4'-BNA bearing a 2-pyridine nucleobase for CG base pair recognition in the parallel motif triplex DNA.
    Hari Y; Matsugu S; Inohara H; Hatanaka Y; Akabane M; Imanishi T; Obika S
    Org Biomol Chem; 2010 Sep; 8(18):4176-80. PubMed ID: 20648389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bridged nucleic acid analogues for antigene technology.
    Obika S
    Chem Pharm Bull (Tokyo); 2004 Dec; 52(12):1399-404. PubMed ID: 15577233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective formation of stable triplexes including a TA or a CG interrupting site with new bicyclic nucleoside analogues (WNA).
    Sasaki S; Taniguchi Y; Takahashi R; Senko Y; Kodama K; Nagatsugi F; Maeda M
    J Am Chem Soc; 2004 Jan; 126(2):516-28. PubMed ID: 14719949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of T.A interruption by 2',4'-BNAs bearing heteroaromatic nucleobases through parallel motif triplex formation.
    Obika S; Inohara H; Hari Y; Imanishi T
    Bioorg Med Chem; 2008 Mar; 16(6):2945-54. PubMed ID: 18255299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of artificial nucleic acid that recognizes a CG base pair in triplex DNA formation].
    Hari Y
    Yakugaku Zasshi; 2013; 133(11):1201-8. PubMed ID: 24189561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.
    Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and triplex forming ability of conformationally locked oligonucleotides containing unnatural nucleobases: efficient recognition of a C.G interruption.
    Obika S; Hari Y; Sekiguchi M; Imanishi T
    Nucleic Acids Symp Ser; 2000; (44):131-2. PubMed ID: 12903303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triplex formation involving 2',4'-BNA with 2-pyridone base analogue: efficient and selective recognition of C:G interruption.
    Torigoe H; Hari Y; Obika S; Imanishi T
    Nucleic Acids Res Suppl; 2001; (1):281-2. PubMed ID: 12836374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of triplex formation by 2'-O,4'-C-aminomethylene bridged nucleic acid (2',4'-BNA NC) modification.
    Sasaki K; Rahman SM; Obika S; Imanishi T; Torigoe H
    Nucleic Acids Symp Ser (Oxf); 2008; (52):419-20. PubMed ID: 18776432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of triplex formation by 3'-amino-2'-O,4'-C-methylene bridged nucleic acid modification.
    Sasaki K; Rahman SM; Sato N; Obika S; Imanishi T; Torigoe H
    Nucleic Acids Symp Ser (Oxf); 2009; (53):159-60. PubMed ID: 19749309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triplex formation involving 2'-O,4'-C-methylene bridged nucleic acid (2',4'-BNA) with 2-pyridone base analogue: efficient and selective recognition of C:G interruption.
    Torigoe H; Hari Y; Obika S; Imanishi T
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1097-9. PubMed ID: 14565353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification of triplex-forming oligonucleotide to promote pyrimidine motif triplex formation at physiological pH.
    Torigoe H; Nakagawa O; Imanishi T; Obika S; Sasaki K
    Biochimie; 2012 Apr; 94(4):1032-40. PubMed ID: 22245184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrupted 2'-o,4'-C-aminomethylene bridged nucleic acid modification enhances pyrimidine motif triplex-forming ability and nuclease resistance under physiological condition.
    Torigoe H; Rahman SM; Takuma H; Sato N; Imanishi T; Obika S; Sasaki K
    Nucleosides Nucleotides Nucleic Acids; 2011 Jan; 30(1):63-81. PubMed ID: 21259164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
    Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
    Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bridged nucleic acids (BNAs) as a basic material for genome technology].
    Obika S
    Yakugaku Zasshi; 2004 Nov; 124(11):781-90. PubMed ID: 15516805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-O,4'-C-aminomethylene-bridged nucleic acid modification with enhancement of nuclease resistance promotes pyrimidine motif triplex nucleic acid formation at physiological pH.
    Torigoe H; Rahman SM; Takuma H; Sato N; Imanishi T; Obika S; Sasaki K
    Chemistry; 2011 Feb; 17(9):2742-51. PubMed ID: 21264967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triplex formation involving 2'-O,4'-C-methylene bridged nucleic acid (2',4'-BNA) with 1-isoquinolone base analogue: efficient and selective recognition of C:G interruption.
    Torigoe H; Hari Y; Obika S; Imanishi T
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1571-3. PubMed ID: 14565468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.